Attenuated ibv with extended cell culture and tissue tropism
AssigneeBoehringer Ingelheim Vetmedica GmbH
InventorsEgbert Siegfried MUNDT, Annika KRAEMER-KUEHL, Rosalba DE LA MORA QUIROZ, Jose Francisco ROBLES GONZALEZ, Thomas Min Stephan
Life of this patent
Estimating the term…
Abstract
The present invention relates i.a. to an IBV (infectious bronchitis virus) deposited with the BVR of IZSLER under accession number DPS RE RSCIC 16, any descendant IBV thereof and any IBV having all of the identifying characteristics of the deposited IBV. Further, the present invention relates to an immunogenic composition comprising said deposited IBV.
Claims20
An IBV (infectious bronchitis virus) deposited with the BVR of IZSLER under accession number DPS RE RSCIC 16, any descendant IBV thereof or any IBV having all of the identifying characteristics of the IBV deposited under DPS RE RSCIC 16.
An IBV (infectious bronchitis virus) deposited with the BVR of IZSLER under accession number DPS RE RSCIC 16, any attenuated descendant IBV thereof having an extended cell culture or tissue tropism and being protective against virulent M41 challenge or any attenuated IBV having an extended cell or tissue tropism and being protective against virulent M41 challenge.
Dependencies are inferred from the claim text.